Minocycline but not tigecycline is neuroprotective and reduces the neuroinflammatory response induced by the superimposition of sepsis upon traumatic brain injury
- PMID: 24810523
- DOI: 10.1097/CCM.0000000000000414
Minocycline but not tigecycline is neuroprotective and reduces the neuroinflammatory response induced by the superimposition of sepsis upon traumatic brain injury
Abstract
Objective: The development of sepsis in patients with traumatic brain injury increases mortality, exacerbates morphological and functional cerebral damage, and causes persistent neuroinflammation, including microglial activation. The administration of antibiotics possessing both antimicrobial and immunomodulatory activity might attenuate both sepsis and posttraumatic cerebral inflammation. We compared the potential therapeutic efficacy of two tetracyclines, minocycline and the newer generation tigecycline, on functional neurobehavioral impairment and regional histopathological damage in an experimental model of combined traumatic brain injury and sepsis.
Design: Prospective, experimental animal study.
Setting: University Research Laboratory.
Subjects: Adult male Sprague-Dawley rats.
Interventions: Controlled cortical impact was used to induce traumatic brain injury and cecal ligation and puncture for sepsis. Immediately following injury, animals were treated with minocycline (45 mg/kg intraperitoneal), tigecycline (7.5 mg/kg intraperitoneal), or saline every 12 hours for 3 days.
Measurements and main results: The development of sepsis and cerebral inflammatory response were evaluated, respectively, by 1) growth of peritoneal microorganisms and clinical variables and 2) tumor necrosis factor-α expression in the perilesional cortex. To assess posttraumatic outcome, vestibulomotor and cognitive function were evaluated at different time points for 14 days post injury whereupon animals were killed and cerebral tissue analyzed for lesion volume, regional hippocampal (CA1/CA3) cell death, and microglial activation in the perilesional cortex, lesion core zone, and choroid plexus. Treatment with both antibiotics reduced microorganism growth, body weight loss, and mortality but had no effect on vestibulomotor or cognitive function. Minocycline alone attenuated postinjury cortical lesion volume, hippocampal CA3 neuronal cell loss, tumor necrosis factor-α expression, and the extent of microglial activation and infiltration.
Conclusions: The significantly heightened mortality caused by the superimposition of sepsis upon traumatic brain injury can be reduced by administration of both antibiotics but only minocycline can decrease the extent of cell death in selectively cortical and hippocampal brain regions, via, in part, a reduction in cerebral inflammation.
Comment in
-
Tetracyclines in traumatic brain injury and sepsis: same, same, but different!*.Crit Care Med. 2014 Aug;42(8):1965-6. doi: 10.1097/CCM.0000000000000445. Crit Care Med. 2014. PMID: 25029146 No abstract available.
Similar articles
-
Tetracyclines in traumatic brain injury and sepsis: same, same, but different!*.Crit Care Med. 2014 Aug;42(8):1965-6. doi: 10.1097/CCM.0000000000000445. Crit Care Med. 2014. PMID: 25029146 No abstract available.
-
Systemic sepsis exacerbates mild post-traumatic brain injury in the rat.J Neurotrauma. 2009 Sep;26(9):1547-56. doi: 10.1089/neu.2008.0723. J Neurotrauma. 2009. PMID: 19257801
-
Minocycline Transiently Reduces Microglia/Macrophage Activation but Exacerbates Cognitive Deficits Following Repetitive Traumatic Brain Injury in the Neonatal Rat.J Neuropathol Exp Neurol. 2016 Mar;75(3):214-26. doi: 10.1093/jnen/nlv021. Epub 2016 Jan 29. J Neuropathol Exp Neurol. 2016. PMID: 26825312 Free PMC article.
-
Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention.Brain Behav Immun. 2012 Nov;26(8):1191-201. doi: 10.1016/j.bbi.2012.06.008. Epub 2012 Jun 21. Brain Behav Immun. 2012. PMID: 22728326 Review.
-
Neuroinflammation: beneficial and detrimental effects after traumatic brain injury.Inflammopharmacology. 2013 Aug;21(4):309-20. doi: 10.1007/s10787-012-0164-2. Epub 2013 Jan 8. Inflammopharmacology. 2013. PMID: 23296919 Review.
Cited by
-
Deplete and repeat: microglial CSF1R inhibition and traumatic brain injury.Front Cell Neurosci. 2024 Feb 21;18:1352790. doi: 10.3389/fncel.2024.1352790. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38450286 Free PMC article. Review.
-
Current state of neuroprotective therapy using antibiotics in human traumatic brain injury and animal models.BMC Neurosci. 2024 Feb 29;25(1):10. doi: 10.1186/s12868-024-00851-6. BMC Neurosci. 2024. PMID: 38424488 Free PMC article. Review.
-
A pre-existing Toxoplasma gondii infection exacerbates the pathophysiological response and extent of brain damage after traumatic brain injury in mice.J Neuroinflammation. 2024 Jan 9;21(1):14. doi: 10.1186/s12974-024-03014-w. J Neuroinflammation. 2024. PMID: 38195485 Free PMC article.
-
Navigating the Complexities of Traumatic Encephalopathy Syndrome (TES): Current State and Future Challenges.Biomedicines. 2023 Nov 27;11(12):3158. doi: 10.3390/biomedicines11123158. Biomedicines. 2023. PMID: 38137378 Free PMC article. Review.
-
High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy.Cells. 2023 Apr 4;12(7):1088. doi: 10.3390/cells12071088. Cells. 2023. PMID: 37048161 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous